BElIMUMAB

Clinical Indication

Active autoantibody-positive systemic lupus erythematosus. Rheumatology only

Date of classification

August 2021

Review date

August 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).